BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 5003209)

  • 1. Central nervous system actions of some synthetic tetrahydrocannabinol derivatives.
    Domino EF; Hardman HF; Seevers MH
    Pharmacol Rev; 1971 Dec; 23(4):317-36. PubMed ID: 5003209
    [No Abstract]   [Full Text] [Related]  

  • 2. General pharmacological actions of some synthetic tetrahydrocannabinol derivatives.
    Hardman HF; Domino EF; Seevers MH
    Pharmacol Rev; 1971 Dec; 23(4):295-315. PubMed ID: 5002533
    [No Abstract]   [Full Text] [Related]  

  • 3. General and behavioral pharmacology.
    Harris LS
    Pharmacol Rev; 1971 Dec; 23(4):285-94. PubMed ID: 4943947
    [No Abstract]   [Full Text] [Related]  

  • 4. Some behavioral effects of delta9 -tetrahydrocannabinol in rats.
    Pradhan SN; Bailey PT; Ghosh B
    Res Commun Chem Pathol Pharmacol; 1972 Mar; 3(2):197-204. PubMed ID: 4610672
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of molindone on CNS structures: neurophysiological and behavioral correlations.
    Guerrero-Figueroa R; Guerrero-Figueroa E; Sneed GA; Gallant DM
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):508-19. PubMed ID: 4198314
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic marijuana usage and sleep-wakefulness cycles in cats.
    Barratt ES; Adams PM
    Biol Psychiatry; 1973 Jun; 6(3):207-14. PubMed ID: 4354505
    [No Abstract]   [Full Text] [Related]  

  • 7. Structure-activity relationships in the tetrahydrocannabinol series. Modifications on the aromatic ring and it the side-chain.
    Edery H; Grunfeld Y; Porath G; Ben-Zvi Z; Shani A; Mechoulam R
    Arzneimittelforschung; 1972 Nov; 22(11):1995-2003. PubMed ID: 4633591
    [No Abstract]   [Full Text] [Related]  

  • 8. [Contribution on the pharmacology of gamma-butyrolactone].
    Hampel H; Hapke HJ
    Arch Int Pharmacodyn Ther; 1968 Feb; 171(2):306-22. PubMed ID: 5685835
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of aziprine on the central nervous system].
    Ponomareva AG
    Farmakol Toksikol; 1969; 32(4):403-6. PubMed ID: 5357457
    [No Abstract]   [Full Text] [Related]  

  • 10. Cholinergic neurotransmission in the central nervous system.
    Pepeu G
    Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:229-. PubMed ID: 4340733
    [No Abstract]   [Full Text] [Related]  

  • 11. The neuroleptics. 5. Animal behavior.
    Buser P; Cook L; Giurgea C; Jacobsen E; Ray OS; Richelle M; Silverman AP; Stein L; Votava Z
    Mod Probl Pharmacopsychiatry; 1970; 5():85-108. PubMed ID: 5005610
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacological studies on 2-methyl-4-amino-6-methoxy-s-triazine (CV399); with special reference to its central effects].
    Chiba S; Nagawa Y; Yui T
    Nihon Yakurigaku Zasshi; 1970; 66(1):64-75. PubMed ID: 4393359
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of 6-hydroxydopamine on agonistic behaviour elicited by stimulation of the hypothalamus in the cat.
    Johansson G; Pääkkönen T; Ruusunen S; Sandström M; Huttunen M
    Med Biol; 1974 Dec; 52(6):406-14. PubMed ID: 4374614
    [No Abstract]   [Full Text] [Related]  

  • 14. [Possibilities of detecting and differentiating central nervous effects of drugs in animal experiments with special consideration of behavioral-pharmacologic methods].
    Hoffmeister F; Wuttke W
    Arzneimittelforschung; 1975 Jul; 25(7a):1162-78. PubMed ID: 241358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological studies of oxazolazepam, a new psychotropic agent. I. Actions on the central nervous system, especially on the behavioral aspect].
    Takagi H; Kamioka T; Kobayashi S; Suzuki Y; Tachikawa R
    Nihon Yakurigaku Zasshi; 1970; 66(1):107-33. PubMed ID: 4987943
    [No Abstract]   [Full Text] [Related]  

  • 16. On the pharmacology of marihuana.
    Gershon S
    Behav Neuropsychiatry; 1970 Jan; 1(10):9-18. PubMed ID: 4908416
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of hydroxyzine and oxylidine on the central nervous system].
    Novikova GV; Komendantova MV
    Farmakol Toksikol; 1971; 34(2):131-5. PubMed ID: 4397903
    [No Abstract]   [Full Text] [Related]  

  • 18. 1-hydroxy-3-amino-pyrrolidone-2 (HA-966). I. Behaviour and motor effects.
    Bonta IL; De Vos CJ; Hillen FC
    Arch Int Pharmacodyn Ther; 1969 Dec; 182(2):391-3. PubMed ID: 4984370
    [No Abstract]   [Full Text] [Related]  

  • 19. [Neuropharmacologic study on the effect of nitrazepam on the central nervous system].
    Yamamoto K; Sawada T; Naito Y; Kido R
    No To Shinkei; 1969 May; 21(5):488-502. PubMed ID: 4980684
    [No Abstract]   [Full Text] [Related]  

  • 20. [Neuropharmacological investigation of serotonin].
    Shibuya T
    Zasshi Tokyo Ika Daigaku; 1969; 27(2):257-67. PubMed ID: 4980366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.